Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00392795 · ClinicalTrials.gov registry record

The BRAIN Intensive Care Unit (ICU) Study: Bringing to Light the Risk Factors

A clinical trial of Dementia and Delirium, sponsored by Vanderbilt University Medical Center.

Active
Registry status
826
Enrollment target
2
Study locations

NCT00392795 is a study of Dementia and Delirium that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 826 participants, below the 7,719-participant average among 199 other Dementia trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00392795, a study of Dementia and Delirium, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.

ACTIVE NOT RECRUITING
Registry status
826 participants
Enrollment target
2
Study locations

Study Summary

The primary purpose of this proposal will be to identify potentially modifiable risk factors of long-term cognitive impairment (i.e. development of delirium and exposure to sedative and analgesic medications) in ICU patients. The investigators will quantify the independent contribution of these risk factors to the incidence of long-term cognitive impairment, controlling for other established risk factors including age, pre-existing cognitive impairment, and apolipoprotein E (apoE) genotype. Quantifying the contributions of these modifiable risk factors will pave the way for the development of preventive and/or treatment strategies to reduce the incidence, severity and/or duration of long-term cognitive impairment and improve functional recovery for patients with critical illness.

Study Locations (2)

Tennessee

  • Saint Thomas Hospital - Nashville
  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 826 participants
Start Date 2007-01
Est. Completion 2026-12

What the Registry Record Tells You About NCT00392795

The ClinicalTrials.gov registry entry for NCT00392795 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 826 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,719-participant average among 199 other Dementia trials with a reported enrollment target (89% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Dementia appearing as the primary indexed condition, and to 0 interventions.

NCT00392795 reports 2 study locations spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT00392795 about?

NCT00392795 is a clinical study titled "The BRAIN Intensive Care Unit (ICU) Study: Bringing to Light the Risk Factors". The primary purpose of this proposal will be to identify potentially modifiable risk factors of long-term cognitive impairment (i.e. development of delirium and exposure to sedative and analgesic medications) in ICU patients. The investigators will quantify the independent contribution of these risk...

What is the current status of trial NCT00392795?

This trial is currently active not recruiting. The enrollment target is 826 participants. The study started on 2007-01. Estimated completion is 2026-12.

What conditions does trial NCT00392795 study?

This clinical trial studies the following conditions: Dementia, Delirium, Cognition Disorders.

Who is sponsoring clinical trial NCT00392795?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00392795 being conducted?

This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.